RASSF1 and melanoma: Hoon and colleagues examined the serum of patients with melanoma and discovered that the incidence of TSG hypermethylation increased during tumour progression and that specifically the hypermethylation of MGMT, RASSF1A and DAPK was significantly higher in metastatic tumours compared to primary melanoma tumours [127].